---
id: nontyphoidal-salmonella_059
category: organisms
tags: [salmonella, nontyphoidal-salmonella, gastroenteritis, bacteremia, when-to-treat]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Nontyphoidal Salmonella (NTS): Gastroenteritis & Bacteremia

**Q:** What are the clinical features, indications for antibiotic treatment, and management of nontyphoidal Salmonella infections?

**A:**

**Microbiology:**
- **Gram-negative rods** (Enterobacterales family)
- **>2,500 serotypes** (serogroups based on O and H antigens)
- Common serotypes: Enteritidis, Typhimurium, Newport, Heidelberg
- NOT Salmonella typhi or paratyphi (those cause typhoid/paratyphoid fever)

**Epidemiology:**
- **1.35 million infections/year in US** (~450 deaths)
- Foodborne: Poultry, eggs, reptiles (turtles, iguanas), contaminated produce
- Transmission: Fecal-oral, contaminated food/water

---

**Clinical Syndromes:**

**1. Gastroenteritis (Most Common - 95%):**

**Incubation:** 6-72 hours (typically 12-36 hours)

**Clinical Features:**
- **Diarrhea:** Watery or bloody (inflammatory)
- **Fever** (70-80%)
- **Abdominal cramps, nausea, vomiting**
- **Headache, myalgias**

**Duration:** 4-7 days (self-limited)

**Fecal shedding:** 4-5 weeks (median), can persist months

**2. Bacteremia (5-10% of cases):**

**Risk Factors for Invasive Disease:**
- **Extremes of age:** Infants (<1 year), elderly (>65 years)
- **Immunosuppression:** HIV/AIDS, transplant, steroids, biologics
- **Hemoglobinopathies:** Sickle cell disease
- **Chronic diseases:** Malignancy, cirrhosis, diabetes, renal failure
- **Achlorhydria:** PPI use, gastric surgery
- **Atherosclerosis/vascular disease** (risk for mycotic aneurysm)

**Clinical Features:**
- Persistent fever
- Bacteremia without GI symptoms (in some cases)
- Risk for **focal infections** (endovascular, meningitis, osteomyelitis)

**Mortality:** ~5% (higher in immunocompromised)

**3. Focal Extraintestinal Infections (Rare):**
- **Endovascular:** Mycotic aneurysms (especially aortic), endocarditis
- **Bone/joint:** Osteomyelitis (especially sickle cell), septic arthritis
- **Meningitis:** Neonates and infants
- **Abscess:** Hepatosplenic, renal

---

**Diagnosis:**

**Stool Culture:**
- Gold standard for gastroenteritis
- Requires selective media

**Blood Cultures:**
- 2 sets if suspected bacteremia or high-risk patient

**PCR (Multiplex GI Panels):**
- Rapid, sensitive
- Does NOT provide antibiotic susceptibilities

---

**Treatment:**

**Key Principle:** **Most gastroenteritis does NOT require antibiotics**

**1. Uncomplicated Gastroenteritis (Supportive Care ONLY):**

**Indications for NO Antibiotics:**
- Immunocompetent
- Mild-moderate symptoms
- No signs of invasive disease

**Rationale:**
- **Antibiotics do NOT shorten illness duration**
- **Prolong fecal shedding** (4-5 weeks → several months)
- ↑ Resistance

**Supportive Care:**
- Oral rehydration
- Anti-motility agents (if non-bloody diarrhea, no fever)
- Self-limited in 4-7 days

**2. Antibiotic Indications (High-Risk for Invasive Disease):**

**Treat IF Any of the Following:**
- **Age:** Infants <3 months (some say <12 months), elderly >65 years
- **Immunocompromised:** HIV (CD4 <200), transplant, biologics, chronic steroids
- **Hemoglobinopathies:** Sickle cell disease, thalassemia
- **Chronic diseases:** Cirrhosis, malignancy, uremia
- **Prosthetic material:** Vascular grafts, prosthetic joints, heart valves
- **Severe gastroenteritis:** High fever (>39°C), bloody diarrhea, dehydration
- **Suspected/confirmed bacteremia**
- **Evidence of extraintestinal infection**

**Antibiotic Options (for Invasive/High-Risk Cases):**

| **Indication** | **Antibiotic** | **Dosing** | **Duration** |
|----------------|----------------|------------|--------------|
| **Uncomplicated (high-risk)** | Fluoroquinolone | Ciprofloxacin 500 mg PO BID | 5-7 days |
| | OR Azithromycin | 1g PO x1, then 500 mg daily | 5-7 days |
| | OR Ceftriaxone | 2g IV daily | 5-7 days |
| **Bacteremia** | Fluoroquinolone or ceftriaxone | Same as above | **10-14 days** |
| **Endovascular (mycotic aneurysm, endocarditis)** | Ceftriaxone ± surgery | 2g IV daily | **≥6 weeks** |
| **Osteomyelitis/septic arthritis** | Fluoroquinolone or ceftriaxone | Same as above | **4-6 weeks** |
| **Meningitis** | Ceftriaxone or cefotaxime | 2g IV q12h | **≥4 weeks** |

**Resistance Considerations:**
- **Fluoroquinolone resistance:** 41% in travelers returning from Asia
- **Life-threatening infections:** Use ceftriaxone + fluoroquinolone until susceptibilities known

---

**Special Considerations:**

**Sickle Cell Disease:**
- High risk for **Salmonella osteomyelitis** (more common than Staph aureus!)
- Always treat bacteremia (even if asymptomatic GI source)
- Prolonged antibiotics (4-6 weeks)

**HIV/AIDS:**
- Recurrent NTS bacteremia common (CD4 <200)
- May require **chronic suppressive therapy** (fluoroquinolone daily) if recurrent

**Mycotic Aneurysms:**
- Older adults with atherosclerosis + NTS bacteremia → high risk
- Imaging (CT angio) if persistent fever despite antibiotics
- Requires prolonged antibiotics (≥6 weeks) ± surgical repair

**Food Handlers:**
- Exclude from work until **3 negative stool cultures** (spaced ≥24h apart)

---

**Comparison: Nontyphoidal Salmonella vs Typhoid Fever (S. typhi)**

| **Feature** | **Nontyphoidal Salmonella** | **Typhoid Fever (S. typhi)** |
|-------------|----------------------------|------------------------------|
| **Syndrome** | Gastroenteritis (95%) | Systemic febrile illness |
| **Diarrhea** | ✅ Prominent | ❌ Constipation more common early |
| **Bacteremia** | 5-10% | ✅ 100% (by definition) |
| **Rose spots** | ❌ No | ✅ Yes (30%) |
| **Hepatosplenomegaly** | ❌ Rare | ✅ Common |
| **Antibiotics** | Usually NOT needed | **Always required** |
| **Duration** | 4-7 days (self-limited) | Weeks (fatal if untreated) |

---

**Mnemonic: "SAFE to Skip Antibiotics (unless high-risk)"**
- **S**almonella gastroenteritis = **S**upportive care
- **A**ntibiotics prolong shedding
- **F**luoroquinolone if needed (high-risk patients)
- **E**lderly, infants, immunocompromised = treat

**Mnemonic: "HIGH-RISK = Treat NTS"**
- **H**emoglobinopathies (sickle cell)
- **I**mmunosuppressed
- **G**eriatric (>65) or infants (<12 months)
- **H**igh fever + severe symptoms

- **R**esidents (nursing home)
- **I**mplants (prosthetics, grafts)
- **S**ystemic signs (bacteremia)
- **K**hronic diseases (cirrhosis, cancer)

**Clinical Pearls:**
- **Do NOT routinely treat uncomplicated gastroenteritis** (prolongs shedding, no benefit)
- **Sickle cell + fever** → think Salmonella bacteremia/osteomyelitis (treat empirically)
- NTS osteomyelitis in sickle cell is more common than Staph aureus
- **Elderly with atherosclerosis + NTS bacteremia** → high risk for mycotic aneurysm (image!)
- **HIV with CD4 <200** → recurrent NTS bacteremia (may need chronic suppression)
- Fluoroquinolone resistance rising (41% from Asia) → use ceftriaxone if uncertain
- Food handlers must have 3 negative stool cultures before returning to work
- Unlike typhoid fever, NTS gastroenteritis is usually self-limited and does NOT require antibiotics

**Media:** None

**Sources:** [CDC Yellow Book 2024 - Nontyphoidal salmonellosis], [Merck Manual 2024 - NTS infections], [Medscape 2024 - Salmonellosis treatment], [PMC 2019 - Antimicrobials for symptomatic NTS], [UpToDate 2024 - NTS bacteremia], [Queensland Children's Health 2024 - NTS guideline]
